ACOG Practice Bulletin #121, "Long-Acting Reversible Contraception: Implants and Intrauterine Devices," provides recommendations for the use of IUDs and contraceptive implants, the most effective reversible contraceptives. The document provides information for appropriate candidate selection and the management of clinical issues and complications associated with LARC methods. The LARC Program has also developed an educational slide set based on clinical recommendations from Practice Bulletin #121. Click here to access the slide set.
"Long-Acting Reversible Contraception: Intrauterine Devices and the Contraceptive Implant," was recently published as a Clinical Expert Series article in Obstetrics & Gynecology. The article provides a review of LARC methods, including candidate selection, non-contraceptive benefits, and management of complications.
ACOG Committee Opinion #642, "Increasing Access to Contraceptive Implants
and Intrauterine Devices To Reduce Unintended Pregnancy," encourages the consideration of implants and IUDs for all appropriate candidates, including nulliparous women and adolescents, and recommends strategies to reduce barriers and increase access to LARC.
ACOG Committee Opinion #539, "Adolescents and Long-Acting Reversible Contraception: Implants an Intrauterine Devices," recommends the use of IUDs and the contraceptive implant as first-line contraceptive options for sexually active adolescents. The LARC Program has also developed an educational slide set based on clinical recommendations from Committee Opinion #539. Click here to access the slide set.
ACOG Committee Opinion #542, "Access to Emergency Contraception," examines the barriers to use of emergency contraceptive methods and highlights the importance of increasing access to these methods. Age restrictions, cost, insurance coverage, and misconceptions about EC are all unnecessary barriers that continue to keep women from using this safe and effective method to prevent unwanted pregnancies in the first few days after unprotected sex, sexual assault, or contraceptive failure.
The CDC has released the U.S. Selected Practice Recommendations for Contraceptive Use, 2013, a resource offering guidance to health care providers in managing common issues around the initiation and use of specific contraceptive methods.The U.S. Selected Practice Recommendations were produced as a companion piece to the U.S. Medical Eligibility Criteria for Contraceptive Use, 2010. While the U.S. Medical Eligibility Criteria addresses who can use various contraceptive methods, the U.S. Selected Practice Recommendations offers method-specific guidance on common clinical issues, such as what clinical information is needed before method initiation and how to manage side effects.
The Journal of Adolescent Health published a supplement on Long-Acting Reversible Contraception for Adolescents and Young Adults in their April 2013 issue. The supplement features a broad range of current research on LARC, covering topics such as effective contraceptive counseling strategies, myths about LARC, pelvic inflammatory disease and IUD use, cost as a barrier to LARC use in adolescents, and the effect of LARC on rapid repeat pregnancy in adolescents.
The CDC has released an iPhone/iPad application for the US Medical Eligibility Criteria for Contraceptive Use, 2010 (US MEC).This new tool gives providers an interactive way to access more than 1,800 recommendations for the safety of contraceptive methods among women and men with certain characteristics or medical conditions. Click here to download the application to your iPhone or iPad. Click here for ACOG Committee Opinion #505, Understanding and Using the U.S. Medical Eligibility Criteria for Contraceptive Use, 2010.